Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MIST

+ Watchlist+ Portfolio

Milestone Pharmaceuticals Inc.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.41
52-Week Range
$0.36 – $3.06
Market Cap
$57.32M
P/E (TTM)
—
EPS (TTM)
-0.74
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.35
PEG Ratio
—
Return on Equity
-1370.55%
Return on Assets
-45.72%
Gross Margin
93.01%
Operating Margin
-1726.39%
Profit Margin
0.00%
Current Ratio
6.27
Debt/Equity
—
Total Debt
$143.77M
Free Cash Flow
$-53.52M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$55.73M

Market Snapshot

About

Milestone Pharmaceuticals is a biopharmaceutical company developing treatments for cardiovascular conditions, particularly cardiac arrhythmias. The company focuses on therapies for paroxysmal supraventricular tachycardia and other heart rhythm disorders.